“…Stroke frequency (SF; 0.58 ± 0.05; 0.57 ± 0.05; 0.55 ± 0.06 strokes·s(−1)) was similar while distance covered, and average running velocity were significantly lower for T(50) compared to T(10) (76 ± 17; 70 ± 13; 65 ± 11 m min(−1)). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Implementation adherence was assessed through modified medication possession ratio (MPRm), medication refill adherence (MRA), and proportion of days covered (PDC). Patients were grouped based on Medicare coverage. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Patients with a new pharmacy claim for an OAM between July 1, 2010, and December 31, 2017, were followed for 6 months to ascertain their medication adherence, which was defined as a proportion of days covered value of at least 0.8. Average monthly patient OOP costs for OAM prescriptions were categorized as lower OOP costs (quartiles 1-3) and higher OOP costs (quartile 4). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: In a 1 million-covered lives population, it was estimated that 12,006 SHEs would occur annually. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Adherence (measured by proportion of days covered [PDC] and medication possession ratio [MPR]), persistence (< 60-day gap in treatment), discontinuation (> 90-day gap), reinitiation of index drug, switching, and dosing patterns for each index drug were assessed during the 12-month follow-up period. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Methods: Anonymized data on 25(OH)D test results were obtained from the clinical data registry of a tertiary teaching hospital covering the period between 1 January 2015 and 30 June 2021. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Data from four waves were included, covering the ages between 11 and 19 years. Autistic-like features were measured using the Children’s Social Behavior Questionnaire. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Using the Southeast Pacific as a model system, we studied daily accumulation rates, composition, and minimum floating times of AMD with and without epibionts on seven sandy beaches, covering the oceanic environment (Rapa Nui/Easter Island) and three regions (south, centre, north) along the Chilean continental coast, over a minimum of 10 consecutive days, and we contrast our results with predictions from published models. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Plans tended to cover drugs with higher (less favorable) CERs more restrictively than drugs with CERs less than $100,000 per QALY: odds ratio (OR) = 4.48 if $100,000-$175,000 per QALY; OR = 2.00 if $175,000-$500,000 per QALY; and OR = 2.10 if $500,000 or more per QALY (all P < 0.01). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…For acute episodes and remission periods, health plans covered most costs; however, there were additional patient-incurred out-of-pocket costs.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Adherence (proportion of days covered [PDC]) to oral antihypertensive and/or antidiabetic therapy was calculated 6 months before and after the first nonadherence diagnosis identified in outpatient encounters, using 2 distinct calculation methods. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Adherence was assessed using the proportion of days covered (PDC), and patients were categorized as adherent with PDC ≥ 0.80. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Finally, a budget impact model for a health plan with 1 million covered lives was also developed. RESULTS: The base case model outputs show costs and calculated effectiveness per attack at $12,905 and 0.806 for rhC1-INH, $14,806 and 0.765 for icatibant, $14,668 and 0.769 for pdC1-INH, and $21,068 and 0.792 for ecallantide, respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Were identified 121 most relevant cited terms covering 7,806 citations. These terms were manually aggregated into 10 topics based on semantic similarity: neutral terms (37.2%), economic aspects (17.6%), in vitro fertilization (IVF) commodities & cross-border reproductive care (CBRC) (10.6%), geographic distribution (9.5%), social aspects (7%), regulation (6%), trends & concerns (3.9%), accessibility (3.4%), internet influence (2.9%), and fertility preservation for non-medical reasons (2%). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…CONCLUSIONS: After controlling for other decision-making factors, we did not find that FDA-expedited approval was associated with faster coverage policy issuance, nor did we find that plans covered drugs the FDA included in expedited review programs less restrictively than drugs excluded from these programs. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…When surgical reconstruction is needed, the location and positioning of this reconstruction is often grouped together with the medial collateral ligament, despite the specific biomechanical role of and the much larger anatomic area covered by the various structures of the posteromedial knee. …”
Enlace del recurso
Enlace del recurso

“…METHODS: A retrospective pre/post longitudinal analysis of pharmacy claims data was performed for 77 participants in a combined VBID/MTM program and 77 eligible nonparticipants, matched by the baseline adherence metrics of proportion of days covered (PDC) and number of days without therapy, also known as gaps in therapy (GIT). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Many health plans use claims-based measures like medication possession ratios or proportion of days covered (PDC) to measure patient adherence to antipsychotics. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Adherence was measured using medication possession ratio (MPR) and proportion of days covered (PDC) at 6 and 12 months post-index. Risk factors of poor adherence (PDC < 80%) were assessed using a logistic regression. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The model compared the total annual costs for a health plan with 1 million covered lives in a scenario in which afatinib share increased 5 percentage points annually to one in which all treatment shares remained constant over time. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso